Remdesivir will cost around $3,120 for patients with private insurance
Image Credit: Reuters
Remdesivir, Gilead’s COVID-19 drug will cost $3,120 for patients on private insurance, while those on government health programs in the United States, will be charged $2,340.
Gilead will charge the government $390 per dose, while hospitals will be charged $520 per dose. Most patients would require 5- day treatment course. Those that require a longer treatment course, will have to have the drug for an additional 5 days.
The steep price was immediately criticised, with a consumer group calling this ‘an outrage’, since Gilead received $70 million in public funding.